News details
 
Information title

Prostate cancer drug reduces testosterone levels in as little as 3 days

Published on Wednesday 03 December 2008 - 06:00

Summary :
Men who took degarelix for prostate cancer saw their testosterone and PSA levels drop in as little as three days. An important feature of the drug is that it does not cause the initial increase in...
Read more

Information source

EurekAlert! - Breaking News

http://www.eurekalert.org

Website description
EurekAlert! is an online science news service, sponsored by AAAS, the science society. It features health, science and technology news from leading research institutes.

Articles published on this website : 2 / 7 days - 12 / 30 days

Family history of prostate cancer does not affect Why prostate cancer patients fail hormone deprivation therapy Gay and bisexual African-American men have the lowest New study shows that a cough medicine ingredient Common treatment for chronic prostatitis fails to reduce

Other articles published on other websites on the same day

CBS wants you to have yourself a merry little prostate exam http://www.tvsquad.com/ BOOK REVIEW: Chronic Prostatitis/Chronic Pelvic Pain Syndrome http://content.nejm.org/ Key Anti-Cancer Compound Found In Broccoli http://www.redorbit.com/ Prostate cancer gives birth to nerve cells http://www.healthjockey.com/ Unusual 11 Mid-Day Movers 12/03: OGXI, PPO, BZH, GW Higher; IFX, HSNI, FCX, PALM Lower http://www.streetinsider.com/ Prostate Cancer Drug Reduces Testosterone Levels http://www.redorbit.com/ Cancer Mortality Rate Declines Are Promising http://www.emaxhealth.com/ Skin Cancer and Beyond: What You Need to Know http://www.bestsyndication.com/ Nymox Reports Positive New Clinical Trial Data On Improvement in Urinary Urgency and Frequency Symptoms in Patients On NX-1207 Drug for Prostate... http://www.primenewswire.com/ Takeda dumps GVAX partnership http://www.fiercebiotech.com/

Archives
month -month -
123456
78910111213
14151617181920
21222324252627
28293031
Newsletter
You can receive news by email